June 12, 2018 – CENTERVUE announced that its Board of Directors has appointed Stefano Gallucci as Group Chief Executive Officer.
Luca Marzotto, former CENTERVUE CEO and Chairman of the Board of Directors, will remain on the board and assume the role of Chairman.
“It is the perfect time to join CENTERVUE” said Gallucci, “Today’s pace of change is exponential. CENTERVUE is a gamechanger in the diagnosis and management of ocular pathologies with disruptive solutions that have become market standards. There are big opportunities ahead that we are addressing with the spirit and determination of a young Company but also with the maturity of an expert team. I am confident this new chapter will be even more impactful and exciting than our start-up first growth. I am now focused on accelerating innovation and execution that our customers need. At a time when our industry is facing even more disruption than we have ever encountered, I could not be more honored to lead this great company.”
Gallucci had previously joined CENTERVUE as President and CEO from 2012 to 2014, guiding the initial growth from startup to a brand recognized worldwide.
From 2014 to 2018 was appointed CEO of Santex Rimar Group, one of the biggest players among machinery manufacturers for the textile industry controlled by the same CENTERVUE shareholders, where Gallucci significantly contributed to the Group remarkable success story.
Founded in 2008, CENTERVUE has become a brand in the eyecare practice and CENTERVUE diagnostic systems are setting new standards to help professionals save patients eyesight with early detection. The Group is today based in Italy and California.
At CENTERVUE, we strive to change our world for the better. We don’t just envision it, we change the game of ocular pathologies diagnosis every day at CENTERVUE. And we can do it faster and better than ever before. We innovate with fresh ideas and possibilities to shape the future because our customers expect us to. We want to make a meaningful difference for our people, doctors and patients using our systems to create shared success that will benefit everyone.